Actively Recruiting
Azithromycin for Meningococcal Carriage
Led by Emory University · Updated on 2025-11-10
1120
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
Sponsors
E
Emory University
Lead Sponsor
C
Centers for Disease Control and Prevention
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to determine the effectiveness of azithromycin in the eradication of nasopharyngeal carriage of N. meningitidis
CONDITIONS
Official Title
Azithromycin for Meningococcal Carriage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to provide their own informed consent and understand study procedures
- Undergraduate and graduate students attending Emory University affiliated campuses who reside in university affiliated housing or off-campus housing (undergraduates)
You will not qualify if you...
- University faculty and staff
- Currently pregnant or breast feeding
- History of immediate or moderate-to-severe allergic reactions to azithromycin
- Taken systemic antibiotics for any reason in the 30 days prior to enrollment
- Having any symptoms of acute illness at the time of screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, United States, 30030
Actively Recruiting
Research Team
P
Paulina Rebolledo, MD, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here